New combo shows promise for tough leukemia cases
NCT ID NCT05029141
First seen Mar 19, 2026 · Last updated May 14, 2026 · Updated 5 times
Summary
This study tests a combination of three drugs (chidamide, azacytidine, and a chemotherapy regimen called HAG) in adults aged 18 to 70 with acute myeloid leukemia that has come back or not responded to standard treatment. The goal is to see if this combination can shrink or eliminate the cancer and to monitor side effects. The trial involves 21 participants and is currently active but not recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affliated Hospital of Soochow University
Suzhou, Jiangsu, 215006, China
Conditions
Explore the condition pages connected to this study.